These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 16256250)
1. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. Deloria-Knoll M; Steinhoff M; Semba RD; Nelson K; Vlahov D; Meinert CL Vaccine; 2006 Mar; 24(10):1670-9. PubMed ID: 16256250 [TBL] [Abstract][Full Text] [Related]
2. Immunization with the heptavalent pneumococcal conjugate vaccine in Bangladeshi infants and effects of zinc supplementation. Osendarp SJ; Prabhakar H; Fuchs GJ; van Raaij JM; Mahmud H; Tofail F; Santosham M; Black RE Vaccine; 2007 Apr; 25(17):3347-54. PubMed ID: 17289221 [TBL] [Abstract][Full Text] [Related]
3. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity. Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children. Spoulou VI; Tsoumas DL; Papaevangelou VG; Mostrou GI; Theodoridou MC Vaccine; 2005 Nov; 23(46-47):5289-93. PubMed ID: 16054732 [TBL] [Abstract][Full Text] [Related]
6. Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial. Søgaard OS; Lohse N; Harboe ZB; Offersen R; Bukh AR; Davis HL; Schønheyder HC; Østergaard L Clin Infect Dis; 2010 Jul; 51(1):42-50. PubMed ID: 20504165 [TBL] [Abstract][Full Text] [Related]
7. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants. Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H; Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452 [TBL] [Abstract][Full Text] [Related]
10. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. Prymula R; Chlibek R; Splino M; Kaliskova E; Kohl I; Lommel P; Schuerman L Vaccine; 2008 Aug; 26(35):4563-70. PubMed ID: 18602724 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I; Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288 [TBL] [Abstract][Full Text] [Related]
14. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Madhi SA; Adrian P; Kuwanda L; Jassat W; Jones S; Little T; Soininen A; Cutland C; Klugman KP Vaccine; 2007 Mar; 25(13):2451-7. PubMed ID: 17023095 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age. Miernyk KM; Butler JC; Bulkow LR; Singleton RJ; Hennessy TW; Dentinger CM; Peters HV; Knutsen B; Hickel J; Parkinson AJ Clin Infect Dis; 2009 Jul; 49(2):241-8. PubMed ID: 19522655 [TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. Madhi SA; Klugman KP; Kuwanda L; Cutland C; Käyhty H; Adrian P J Infect Dis; 2009 Apr; 199(8):1168-76. PubMed ID: 19265481 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease. Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446 [TBL] [Abstract][Full Text] [Related]
18. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035 [TBL] [Abstract][Full Text] [Related]
19. The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years. Goldblatt D; Southern J; Andrews N; Ashton L; Burbidge P; Woodgate S; Pebody R; Miller E Clin Infect Dis; 2009 Nov; 49(9):1318-25. PubMed ID: 19814624 [TBL] [Abstract][Full Text] [Related]